Suppr超能文献

[子宫内膜异位症的医学治疗:醋酸亮丙瑞林与达那唑的对比研究]

[Medical treatment of endometriosis: comparative study of leuprolide acetate and danazol].

作者信息

Palagiano A, Capuano V

机构信息

I Clinica Ostetrica e Ginecologica, II Università degli Studi di Napoli.

出版信息

Minerva Ginecol. 1994 Apr;46(4):173-7.

PMID:8065590
Abstract

Hypo-oestrogenaemia following surgical oophorectomy leads to a regression of the ectopic endometrial tissue. A medical and transitory oophorectomy can be obtained using leuprolide ac., an analogue of LH-RH. In this study we compare the results of therapy with danazol or leuprolide in the treatment of endometriosis. Fifty patients affected by endometriosis were selected laparoscopically and recorded under the classification of American Fertility Society. 20-40 year old women who were admitted had not received any therapy for endometriosis within the previous 12 months. They were allocated at random to open treatment with intramuscular injection of leuprolide (3.75 mg/monthly) or oral danazol. The dose regimen used for this last drug was 600 mg/daily in the majority of patients. 47 women completed a six months therapy, and 42 underwent to a second laparoscopy to evaluate the effects of the treatment. Both danazol and leuprolide were associated to a decreasing of clinical symptoms and to adverse effects that we described in this paper.

摘要

手术切除卵巢后出现的低雌激素血症会导致异位子宫内膜组织消退。使用亮丙瑞林(一种促黄体生成素释放激素类似物)可实现药物性和暂时性卵巢切除。在本研究中,我们比较了达那唑或亮丙瑞林治疗子宫内膜异位症的效果。通过腹腔镜选择了50例患有子宫内膜异位症的患者,并根据美国生育协会的分类进行记录。入选的20至40岁女性在过去12个月内未接受过任何子宫内膜异位症治疗。她们被随机分配接受肌肉注射亮丙瑞林(3.75毫克/月)的开放治疗或口服达那唑。大多数患者使用的后一种药物的剂量方案为每日600毫克。47名女性完成了六个月的治疗,42名接受了第二次腹腔镜检查以评估治疗效果。达那唑和亮丙瑞林均与临床症状的减轻以及本文中描述的不良反应相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验